LONDON and REDWOOD CITY, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), “Mereo” or the “Company”, a clinical stage biopharmaceutical company focused on oncology ...
Set to be the largest global gathering of data to date about the impact that Osteogenesis Imperfecta (OI) has on people with OI, families and caregivers LONDON and REDWOOD CITY, Calif., Oct. 13, 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results